Clinical Trial Update: Dendritic Cell Activating Scaffold in Melanoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a Dendritic Cell Activating Scaffold in patients with melanoma has completed the study.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Dendritic Cell Activating Scaffold

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Melanoma | Phase 1 | Status: COMPLETED